Nike Analysts Remain Bearish Despite 'Full Stride Ahead' Plan, Cite Sales Decline In FY28
Nike shares faced pressure as analysts questioned its recovery outlook; JPMorgan and BofA analysts remain bearish on 2028 declines.
Follow the latest Nike, Inc. (NKE) news and market headlines alongside the live NKE price. Stay informed on what's moving NKE.
Nike shares faced pressure as analysts questioned its recovery outlook; JPMorgan and BofA analysts remain bearish on 2028 declines.
Five sectors are trading higher and six are lower in Wednesday's regular session, with growth sectors holding the top three positions. The leaders are separated rather than clustered, with no single gap clearly standing apart from the other breaks across the table.
Barclays analyst Adrienne Yih maintains Nike (NYSE:NKE) with a Overweight and lowers the price target from $45 to $42.
Evercore ISI Group analyst Michael Binetti maintains Nike (NYSE:NKE) with a In-Line and raises the price target from $28 to $35.
Analyst ratings highlight high-yield consumer stocks Vail Resorts, Nike and Newell Brands, offering dividend yields of 4.57%-5.85%.
Nike (NKE) stock slips after warning of a challenging fiscal 2028, even as it unveils its "Full Stride Ahead" growth plan.
Major U.S. indices closed sharply lower on Tuesday, with the Dow Jones Industrial Average tumbling 1.64% to 50,759.42
Nike shares have plummeted 78% from their peak, resulting in a higher dividend yield of 4.29%. However, the company faces persistent revenue declines (down 5% year-over-year), weak management outlook, and concerning dividend coverage issues. Free cash flow of $2.2 billion failed to cover $2.4 billion in dividends, and projected earnings of $1.15-$1.35 per share fall short of the annualized $1.64 dividend. The analyst recommends passing on the stock despite the attractive yield due to ongoing operational challenges.
Nike shares fell 6.3% on November 17, 2026, following its Investor Day presentation of a 'Full Stride Ahead' turnaround strategy. While the company outlined ambitious 2031 targets including $5 billion in incremental revenue growth and 50% earnings growth, investors were concerned about expected sales declines for the next two years before returning to market-level growth in fiscal 2029. Nike plans to return $12 billion in cumulative capital through dividends over the next four years.
Nike shares initially rose 6% after announcing its 'Full Stride Ahead' turnaround plan targeting $5 billion in added revenue and doubled operating margins by 2031, but reversed to trade 5% lower by afternoon. Investors were spooked by the fine print revealing two more years of declining sales before growth returns in fiscal 2029, making the recovery a five-year wait at current valuations.
-Investor Day Event
-Investor Day
Nike unveiled its Full Stride Ahead strategy, reaffirmed fiscal 2027 guidance and outlined financial targets aimed at restoring sustainable, profitable growth through fiscal 2031.
-Semafor Event
-Investor Day
Nike unveiled its 'Full Stride Ahead' five-year turnaround strategy, aiming to nearly double earnings per share from $2.08 to $3-$3.50 by 2031 through athlete endorsements, faster product launches, and cost cuts. While revenue targets of $47.8B fall short of Wall Street's $51B expectations, the profit goals exceed analyst forecasts of $2.95 per share, driving a 2.2% stock gain.
Elon Musk said hiring ousted Nvidia CEO Jensen Huang would be "an honor," backed a petition to reinstate him and captioned a Matt Damon clip with one word.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to NKE, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.